. Cortisol-mediated potentiation of uterine artery contractility: effect of pregnancy. Am J Physiol Heart Circ Physiol 283: H238-H246, 2002. First published February 28, 2002 10.1152/ajpheart.00842.2001.-During pregnancy, maternal plasma cortisol concentrations approximately double. Given that cortisol plays an important role in the regulation of vascular reactivity, the present study investigated the potential role of cortisol in potentiation of uterine artery (UA) contractility and tested the hypothesis that pregnancy downregulated the cortisol-mediated potentiation. In vitro cortisol treatment (3, 10, or 30 ng/ml for 24 h) produced a dose-dependent increase in norepinephrine (NE)-induced contractions in both nonpregnant and pregnant (138-143 days gestation) sheep UA. However, this cortisol-mediated response was significantly attenuated by ϳ50% in pregnant UA. The 11␤-hydroxysteroid dehydrogenase (11-␤HSD) inhibitor carbenoxolone did not change the effect of cortisol in nonpregnant UA but abolished its effect in pregnant UA by increasing the NE pD 2 in control tissues from 6.20 Ϯ 0.05 to 6.59 Ϯ 0.11. The apparent dissociation constant value of NE ␣1-adrenoceptors was not changed by cortisol in pregnant UA but was decreased in nonpregnant UA. There was no difference in glucocorticoid receptor density between nonpregnant and pregnant UA. Cortisol significantly decreased endothelial nitric oxide (NO) synthase protein levels and NO release in both nonpregnant and pregnant UA, but the effect of cortisol was attenuated in pregnant UA by ϳ50%. Carbenoxolone alone had no effects on NO release in nonpregnant UA but was decreased in pregnant UA. These results suggest that cortisol potentiates NE-mediated contractions by decreasing NO release and increasing NE-binding affinity to ␣1-adrenoceptors in nonpregnant UA. Pregnancy attenuates UA sensitivity to cortisol, which may be mediated by increasing type-2 11-␤HSD activity in UA. nitric oxide; ␣1-adrenoceptor; 11-␤HSD; glucocorticoid receptor DURING PREGNANCY IN SEVERAL SPECIES, including humans and sheep, maternal plasma cortisol concentrations approximately double (19, 32) . Whereas the elevation of maternal cortisol may be essential for normal fetal development and homeostasis, either hypercorticism or hypocorticism can result in an increased incidence of fetal growth restriction, prematurity, and fetal or neonatal death. It has been well documented that cortisol plays a key role in the regulation of vascular reactivity and produces a permissive effect in potentiating vasoactive responses to catecholamines through glucocorticoid receptors (GR). Glucocorticoids potentiate vasoconstrictive responses of catecholamines, angiotensin II, vasopressin, and bradykinin, and increased glucocorticoid responsiveness has been associated with an increase in arterial contraction and vascular resistance (5, 10, 18, 22, 41, 42, 48) .
DURING PREGNANCY IN SEVERAL SPECIES, including humans and sheep, maternal plasma cortisol concentrations approximately double (19, 32) . Whereas the elevation of maternal cortisol may be essential for normal fetal development and homeostasis, either hypercorticism or hypocorticism can result in an increased incidence of fetal growth restriction, prematurity, and fetal or neonatal death. It has been well documented that cortisol plays a key role in the regulation of vascular reactivity and produces a permissive effect in potentiating vasoactive responses to catecholamines through glucocorticoid receptors (GR). Glucocorticoids potentiate vasoconstrictive responses of catecholamines, angiotensin II, vasopressin, and bradykinin, and increased glucocorticoid responsiveness has been associated with an increase in arterial contraction and vascular resistance (5, 10, 18, 22, 41, 42, 48) .
The question arises as to whether or to what extent the increased cortisol levels during pregnancy affect uterine artery contractility and blood flow. Despite the increase in maternal plasma cortisol levels, pregnancy is accompanied by a significant increase in uterine blood flow. In vivo studies have demonstrated that pregnancy decreases uterine artery responsiveness to the vasoconstrictor effects of several agents, including angiotensin II and norepinephrine (NE) (25, 30) , although Annibale et al. (1) reported that in vitro there was increased sensitivity of denuded uterine artery smooth muscle to ␣-stimulation. It has been demonstrated that pregnancy is associated with an increase in endothelial nitric oxide (NO) synthase (eNOS) expression and NO synthesis/release in uterine artery endothelial cells, which plays a key role in decreased uterine artery contractility (26, 37, 45, 46, 47) . In the present study, we tested the hypothesis that cortisol potentiated ␣-adrenoceptor-induced contractions of the uterine artery, which was attenuated by pregnancy. Specifically, we examined the effect of cortisol on NEinduced contractions in isolated uterine arteries from both nonpregnant and pregnant sheep. To determine the potential role of endothelial NO in the effect of cortisol and its alteration by pregnancy, we examined the effect of cortisol on NO release and eNOS protein expression in the endothelium of nonpregnant and pregnant uterine arteries. The effect of glucocorticoids on vascular reactivity is regulated by 11␤-hydroxy-steroid dehydrogenase (11-␤HSD) (41) . Both type 1 and 2 11-␤HSD have been found in vascular endothelial (7) and smooth muscle cells (6, 42) ; type 1 11-␤HSD catalyzes predominantly conversion of cortisone to active cortisol, whereas type 2 11-␤HSD converts cortisol to inactive form cortisone. The present study also examined the effect of 11-␤HSD inhibitor carbenoxolone on cortisol-mediated responses in the uterine artery.
METHODS
Tissue preparation. Nonpregnant (with intact ovaries) and pregnant (138-143 days gestation) sheep were anesthetized with thiamylal (10 mg/kg) administered via the external left jugular vein. The ewes were then intubated, and anesthesia was maintained on 1.5-2.0% halothane in oxygen throughout surgery. An incision in the abdomen was made, and the uterus was exposed. The uterine arteries were isolated and removed without stretching and placed into a modified Krebs solution (pH 7.4) of the following composition (in mM): 115.21 NaCl, 4.7 KCl, 1.80 CaCl 2, 1.16 MgSO4, 1.18 KH2PO4, 22.14 NaHCO3, and 7.88 dextrose. EDTA (0.03 mM) was added to suppress oxidation of amines. The Krebs solution was oxygenated with a mixture of 95% O 2-5% CO2. After removal of the tissues, animals were killed with T-61 (euthanasia solution, Hoechst-Roussel; Somerville, NJ). A total of 35 nonpregnant and 34 pregnant sheep were used. All procedures and protocols used in the present study were approved by the Animal Research Committee of Loma Linda University and followed the guidelines put forward in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
The third (nonpregnant) and fourth (pregnant) branches of the main uterine arteries with a similar external diameter (ϳ0.8 mm) were separated from the surrounding tissue, and special care was taken to avoid touching the luminal surface. The arteries were cut into rings of 2 mm in length. For contraction studies, each ring was preincubated in a given culture dish with 2 ml of complete DMEM (Mediatech Cellgro) containing 1% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin. The tissues were incubated at 37°C in a humidified incubator with 5% CO 2-95% air in the absence or presence of cortisol (1, 10, or 30 ng/ml) and/or carbenoxolone (3 M) for 24 h. To determine the role of endothelium in the effect of cortisol, the endothelium was removed from some arterial rings by gentle rotation of the tissue on an appropriately sized, rough-surfaced blunt hypodermic needle as described previously (17) . For NO and eNOS protein measurements, the uterine arteries were cut into segments 20 mm in length. Five segments were placed in a given culture dish with 5 ml DMEM containing 1% fetal bovine serum and penicillin-streptomycin and incubated at 37°C in a humidified incubator with 5% CO 2-95% air in the absence or presence of cortisol (10 ng/ml) and/or carbenoxolone (3 M) for 24 h. After the treatment, a 1-ml sample was taken from the medium for NO measurement, and the endothelium was gently scraped from the vessel lumen of the arterial segments as previously described (26, 46) for determination of eNOS protein levels.
Contraction studies. After cortisol pretreatment, arterial contractions were quantified in the continuous presence of cortisol in Krebs solution in tissue baths at 37°C as described previously (17) . Isometric tensions were measured. After 60 min of equilibration in the tissue bath, each ring was stretched to the optimal resting tension, as determined by the tension developed in response to potassium chloride (120 mM) added at each stretch level. Concentration-response curves were obtained by cumulative addition of NE in approximate one-half log increments. EC 50 values for the agonist in each experiment were taken as the molar concentration at which the contraction-response curve intersected 50% of the maximum response and were expressed as pD 2 (Ϫlog EC 50) values.
The apparent dissociation constant (K A) of NE to ␣-adrenoceptors was determined as previously described (17) . Briefly, the concentration-response curves to NE were determined before and after the treatment of tissues with phenoxybenzamine (30 nM for 20 min) to inactivate a fraction of the receptors and reduce the maximal response to NE by ϳ50%. The reciprocal of the concentration of NE before phenoxybenzamine treatment (1/[A]) was then plotted against the reciprocal of the corresponding equieffective concentrations after the treatment (1/[AЈ]). The values for K A and the fraction of active receptors remaining (q) were calculated as follows (11)
, where K A ϭ (slope Ϫ 1)/intercept and q ϭ 1/slope (12) .
Measurement of NO, nitrite, and nitrate. Cumulated NO release in the culture medium was measured by chemiluminescence method as previously described (50) . Because of the instability of NO in oxygenated physiological solution, most of NO is converted to nitrite and further to nitrate. Nitrite and nitrate are relatively stable in the solution and are readily reduced back to NO in vanadium (III)-HCl solution. Samples (0.5 ml) were deproteinized by the addition of 1 ml cold ethanol followed by vortex mixing for 1 min. After incubation on ice for 30 min, samples were centrifuged at 14,000 rpm for 5 min, and the supernatant was collected. A 50-l aliquot of the supernatant was injected into the gas purge vessel containing 5 ml vanadium (III)-HCl to react for 1 min and reduce nitrate/nitrite in the sample back to NO. To achieve high reducing efficiency, the reduction was performed at 90°C. NO in the sample was then stripped into the head space of the gas purge vessel by bubbling it with helium (12 ml/min) for 60 s. NO in the head space was then drawn into a NO analyzer (model 270B, Sievers Instruments; Boulder, CO) and mixed with ozone (O3) in front of a cooled Hamamastu, red-sensitive photomultiplier tube. The signal from the detector was analyzed by an on-line computer as the area under the peak. The measurement reflected the combined concentrations of nitrite, nitrate, and NO (NOx) of each sample, which were calculated from a standard curve of 10-1,000 pmol nitrate run in each assay.
Western blot analysis of eNOS and GRs. To determine the effect of cortisol on eNOS protein levels, the endothelium was gently scraped from the vessel lumen of the arterial segments after 24-h cortisol treatment as described above. The cells were then solubilized by sonication in lysis buffer (150 mM NaCl, 50 mM Tris ⅐ HCl, 10 mM EDTA, 0.1% Tween 20, 0.1% ␤-mercaptoetanol, 0.1 mM phenylmethylsulfonyl fluoride, 5 g/ml leupeptin, and 5 g/ml aprotinin; pH 7.4). To measure GR protein in uterine artery endothelium and smooth muscle, the endothelium was scraped from the vessel lumen of freshly isolated uterine arteries (the main to third branches) and solubilized. The remaining smooth muscle was homogenized on ice with a Brinkman Polytron in ice-cold TEGMD buffer (20 mM Tris, 1 mM EDTA, 10% glycerol, 10 mM sodium molybdate, and 1 mM dithiothreitol; pH 7.4). The homogenate was centrifuged at 4°C for 45 min at 100,000 g. Protein obtained from both endothelial and smooth muscle samples was quantified in the supernatant using a protein assay kit from Bio-Rad. Western blotting of eNOS was carried out as previously described (45) and that of GR by the method of O'Donnell et al. (33) . Samples were mixed with an equal volume of 2ϫ sample buffer (0.125 M Tris ⅐ HCl, 20% glycerol, 4% SDS, 0.005% bromophenol blue, and 5% ␤-mercaptoetanol) and heated at 95°C for 5 min. Samples with equal protein (10 g for eNOS and 25 g for GR) were loaded onto a 7.5% polyacrylamide gel with 0.1% SDS and separated by electrophoresis at 100 V for 2 h. Proteins were then transferred onto an immobilon-P membrane at 30 V for 60 min at room temperature using a semidry blotter (Bio-Rad). The immobilon-P membrane was probed by mouse monoclonal antiserum for eNOS (1:750, Transduction Laboratories; Lexington, KY) and rabbit polyclonal antibody for glucocorticoid receptor (1:1,000, Affinity Bioreagents; Neshanic Station, NJ). Membranes were washed using Tris-buffered saline and then incubated with horseradish peroxidaseconjugated goat anti-mouse (1:1,000) and goat anti-rabbit (1:2,500) antibodies obtained from Amersham (Arlington Heights, IL). Proteins were visualized with enhanced chemiluminescence (ECL) reagents (Amersham), and the blots were exposed to hyperfilm. Results were quantified by a scanning densitometer (model 670, Bio-Rad). Actin was used to assess equal loading only for within-group analysis.
Materials. NE, cortisol, and carbenoxolone were obtained from Sigma (St. Louis, MO). All electrophoretic and immunoblot reagents were obtained from Bio-Rad Laboratories. All drugs were prepared fresh each day and kept on ice throughout the experiment.
Data analysis. Concentration-response curves were analyzed by computer-assisted nonlinear regression to fit the data using GraphPad Prism (GraphPad software; San Diego, CA). Results were expressed as means Ϯ SE obtained from the number (n) of experimental animals given. Differences were evaluated for statistical significance (P Ͻ 0.05) by one-way ANOVA followed by the Newman-Keuls post hoc test. Figure  1 shows the effect of cortisol on NE-induced contractions of the uterine artery. Cortisol (1, 10, or 30 ng/ml) treatment for 24 h produced a dose-dependent increase, at the given dose range, in NE-induced contractions of nonpregnant uterine arteries and increased NE pD 2 from a control value of 5.60 Ϯ 0.02 to 5.96 Ϯ 0.04 (P Ͻ 0.05), 6.36 Ϯ 0.07 (P Ͻ 0.05), and 6.59 Ϯ 0.06 (P Ͻ 0.05), respectively (Fig. 1A) . In pregnant uterine arteries, the NE-induced contraction was increased compared with nonpregnant uterine arteries (NE pD 2 : 6.21 Ϯ 0.10 vs. 5.60 Ϯ 0.02, P Ͻ 0.05). The low dose (1 ng/ml) of cortisol had no effect on NE-induced contractions in pregnant uterine arteries, but the higher doses (10 and 30 ng/ml) increased NE pD 2 from a control value of 6.21 Ϯ 0.10 to 6.54 Ϯ 0.05 (P Ͻ 0.05) and 6.65 Ϯ 0.09 (P Ͻ 0.05), respectively (Fig. 1B) . However, the degree of cortisol-mediated potentiation of NEinduced contractions was significantly attenuated in pregnant vs. nonpregnant uterine arteries (Fig. 2) . Removal of the endothelium diminished the cortisol (10 ng/ml)-mediated potentiation in both nonpregnant (NE pD 2 : 6.29 Ϯ 0.10 vs. 6.46 Ϯ 0.17, P Ͼ 0.05) and pregnant (6.93 Ϯ 0.15 vs. 7.14 Ϯ 0.29, P Ͼ 0.05) uterine arteries.
RESULTS

Effect of cortisol on NE-induced contractions.
To examine whether the effect of cortisol was arterytype specific, we conducted similar experiments with the femoral artery. As shown in Fig. 3 , cortisol (10 ng/ml) treatment potentiated NE-induced contractions in both nonpregnant (pD 2 : 6.43 Ϯ 0.05 vs. 6.19 Ϯ 0.06, P Ͻ 0.05) and pregnant (pD 2 : 6.26 Ϯ 0.03 vs. 5.81 Ϯ 0.04, P Ͻ 0.05) femoral arteries. The cortisol-mediated potentiation was greater in pregnant versus nonpregnant femoral arteries.
To determine whether cortisol affects agonist-binding affinity of NE to ␣-adrenoceptors in the uterine artery, K A of NE to ␣-adrenoceptors was determined in intact control and cortisol-treated tissues using Furchgott's partial irreversible blockade method. As shown in Fig. 4 , the K A values for NE were higher in nonpregnant (24.6 Ϯ 6.5 M) than pregnant (5.2 Ϯ 2.0 M) uterine arteries (P Ͻ 0.05). After cortisol treatment, there was a significant reduction in NE K A values in nonpregnant, but not in pregnant, uterine arteries (Fig. 4) .
Effect of pregnancy on GR protein levels. Given that effect of cortisol is mediated by the GR, we determined GR protein levels in nonpregnant and pregnant uterine arteries by Western blotting. As shown in Fig. 5 , the GR was recognized by the polyclonal antibody at a band of ϳ97 kDa in both endothelial scrapings and vascular smooth muscle of the uterine artery, which is in agreement with the estimated molecular mass previously reported for rat GR (29) . Quantitative analysis of immunoreactive GR levels indicated that pregnancy did not affect GR protein levels in either endothelial scrapings or smooth muscle of the uterine artery (Fig.  5, bottom) .
Effect of carbenoxolone on cortisol-mediated responses. To test the hypothesis that pregnancy alters 11-␤HSD activity in the uterine artery, the cortisolmediated potentiation of NE-induced contractions was examined in the absence and/or presence of the 11-␤HSD inhibitor carbenoxolone (3 M for 24 h). As shown in Fig. 6 , carbenoxolone had no effect on NEinduced contractions in the absence or presence of cortisol in nonpregnant uterine arteries. In contrast, carbenoxolone potentiated NE-induced contractions of pregnant uterine arteries by increasing the NE pD 2 from 6.20 Ϯ 0.05 to 6.59 Ϯ 0.11 (P Ͻ 0.05) in the absence of cortisol. In the presence of carbenoxolone, Fig. 2 . Cortisol-mediated increase of NE pD2 in pregnant and nonpregnant uterine arteries. The NE pD2 values were obtained from the results shown in Fig. 1 . Data are presented as differences in NE pD2 values between the cortisol-treated tissues and control tissues for nonpregnant and pregnant uterine arteries. Data are means Ϯ SE of 6 animals. * P Ͻ 0.05 vs. nonpregnant uterine arteries. cortisol had no further effect on NE-induced contractions of pregnant uterine arteries (Fig. 6) .
Effect of cortisol on eNOS expression and NO release. Figure 7 shows the effect of cortisol and carbenoxolone on eNOS protein expression in nonpregnant and pregnant uterine artery endothelial scrapings. In agreement with a previous study (45) , the representative Western immunoblot showed that the monoclonal antibody for eNOS detected a single band at the expected size of 140 kDa in both nonpregnant and pregnant uterine artery endothelial scrapings. As shown in Fig.  7 , there was a decrease in eNOS protein expression in both pregnant and nonpregnant uterine artery endothelial scrapings after 24-h pretreatment with cortisol or carbenoxolone, respectively. Although the carbenoxolone-mediated decrease in eNOS protein levels were similar in nonpregnant and pregnant uterine artery endothelial scrapings, the degree of cortisol-induced reduction in eNOS was significantly less in pregnant compared with nonpregnant uterine artery endothelial scrapings (Fig. 8) . Consistent with its effect on eNOS protein levels, cortisol decreased NO release 74% in the nonpregnant uterine artery and 44% in the pregnant uterine artery (Fig. 9) . Carbenoxolone alone had no effects on NO release in nonpregnant uterine artery (103.4 Ϯ 15.0 vs. 86.3 Ϯ 3.8 pmol/50 l, P Ͼ 0.05) but significantly decreased NO release in the pregnant uterine artery (234.5 Ϯ 39.4 vs. 116.3 Ϯ 27.0 pmol/50 l, P Ͻ 0.05; Fig. 9 ).
DISCUSSION
The present study demonstrated that cortisol plays an important role in the regulation of uterine artery contractility. There are several important observations in the present study. First, cortisol potentiated NEmediated contractions in both uterine and femoral arteries from nonpregnant animals. Second, pregnancy selectively attenuated the cortisol-mediated potentiation in the uterine artery. Third, cortisol increased NE-binding affinity to ␣-adrenoceptors selectively in the nonpregnant uterine artery. Fourth, the 11-␤HSD inhibitor carbenoxolone increased NE-induced contractions selectively in the pregnant uterine artery. Fifth, pregnancy did not change GR density in the uterine artery. Sixth, cortisol downregulated eNOS protein expression and decreased NO release in uterine artery endothelium, which was attenuated by pregnancy. Finally, carbenoxolone inhibited NO release selectively in the pregnant uterine artery.
The results that cortisol potentiated NE-induced contractions of uterine and femoral arteries are in Fig. 7 . Effect of cortisol on endothelial nitric oxide (NO) synthase (eNOS) protein levels in the uterine artery. Uterine arteries were pretreated with 10 ng/ml cortisol and 3 M carbenoxolone, respectively, for 24 h at 37°C as indicated in METHODS. Western blot analysis (10 g protein in each lane) of eNOS was then performed in freshly isolated endothelial cells from the uterine arteries. Immunoblots illustrate eNOS bands detected by the monoclonal antibody at the expected size of ϳ140 kDa. Actin was used as a loading control only for within-group analysis. A: nonpregnant uterine arteries; B: pregnant uterine arteries. Data are means Ϯ SE of 5-8 animals. * P Ͻ 0.05 vs. control. agreement with previous findings demonstrating that corticosteroid hormones play an important role in the regulation of vascular reactivity. It has been demonstrated in vivo that adrenalectomy reduces pressor responsiveness to catecholamines, which can be reversed with glucocorticoid replacement (10, 48) . Increased cortisol responsiveness has been associated with an increase in arterial contractile sensitivity to NE and vascular resistance (5, 22, 41, 42) . In contrast, although glucocorticoids have been found to have pronounced stimulatory effect on blood pressure in fetal sheep (11, 39, 44) , betamethasone treatment for 2 days showed no effect on NE-induced contractions of femoral arteries in fetal sheep (2) . This would suggest heterogeneity of glucocorticoid-mediated vascular responses at different developmental stages.
The present study demonstrated, for the first time, that pregnancy attenuated uterine, but not femoral, artery sensitivity to cortisol and decreased cortisolmediated potentiation of NE-induced contractions of the uterine artery. It has been well documented that the effect of cortisol in potentiating vasoactive responses to catecholamines is mediated by the GR in vascular smooth muscle (13, 22, 28) . Given that maternal plasma cortisol concentrations approximately double in sheep (19, 20) and cortisol suppresses the expression of the GR (8), we had expected a decrease in GR density in the pregnant uterine artery. However, immunoreactive GR proteins estimated by Western blotting in the present study were not different in either endothelial scrapings or smooth muscle between nonpregnant and pregnant uterine arteries, suggesting that the pregnancy-associated decrease in uterine artery sensitivity to cortisol was not mediated by decreased GR density. Because immunoreactive GR proteins include both cytosolic and nuclear GR, it is not clear at present whether cytosolic GR availability and binding affinity was altered by pregnancy in the uterine artery. Roesch and Keller-Wood (35) demonstrated differential effects of pregnancy on GR availability and immunoreactivity in the sheep hypothalamus, pituitary, hippocampus, and kidney and suggested significant tissue heterogeneity in the regulation of GR by pregnancy. Because progesterone has antiglucocorticoid effects and binds to GR at a physiological concentration (9), it is speculated that increased progesterone in pregnancy affects uterine artery reactivity locally by decreasing the GR availability in both endothelial scrapings and vascular smooth muscle.
Despite the fundamental importance of cortisol in regulating vascular reactivity to vasoconstrictors, little is currently known about the cellular mechanisms of vascular smooth muscle in response to cortisol. It has been shown that adrenalectomy causes a significant decrease in ␣ 1 -adrenoceptor density in the rat aorta, which is restored by dexamethasone replacement (15) . We have demonstrated that NE contracts the uterine artery by acting on ␣ 1 -adrenoceptors and increasing inositol 1,4,5-trisphosphate (49) . The higher binding affinity of NE to ␣ 1 -adrenoceptors in pregnant than nonpregnant uterine arteries may explain in part the increased NE-induced contractions in pregnant uterine arteries. The present finding that cortisol significantly decreased dissociation constant of NE to ␣ 1 -adrenoceptors in nonpregnant uterine arteries suggests that cortisol-mediated potentiation of NE-induced contractions of nonpregnant uterine arteries was due, at least in part, to the increased NE-binding affinity to ␣ 1 -adrenoceptors. This is in agreement with previous in vivo studies in the dog and in vitro studies in the rabbit aorta in which cortisol was proposed to increase the affinity of catecholamine for the adrenergic receptor (3) . Nevertheless, the effect of cortisol on catecholamine affinity for the adrenergic receptors has not been previously determined. In the present study, in the absence of exogenous cortisol, NE-binding affinity to ␣ 1 -adrenoceptors was greater in pregnant than nonpregnant uterine arteries. Cortisol increased NE-binding affinity to ␣ 1 -adrenoceptors in nonpregnant but not pregnant uterine arteries and eliminated the difference between pregnant and nonpregnant uterine arteries. These studies suggest that increased ␣ 1 -adrenoceptor binding affinity in pregnant compared with nonpregnant uterine arteries may be mediated by an increase in endogenous cortisol binding to GR in the pregnant uterine artery due to elevated cortisol levels in pregnancy. Although the mechanisms underlying cortisol-mediated regulation of agonist-binding affinity are not clear at present, studies have shown that glucocorticoids play a crucial role in maintaining coupling of ␣ 1 -adrenoceptors to G proteins in the rat aorta (15, 16) . This may be an important mechanism by which cortisol regulates receptor-G protein coupling and hence agonist binding affinity in vascular smooth muscle.
The finding that the 11-␤HSD inhibitor carbenoxolone selectively potentiated NE-induced contractions in the pregnant uterine artery by increasing NE pD 2 in the absence of exogenous cortisol suggests a significant level of endogenous cortisol in the freshly isolated tissues of the uterine arteries. Although we cannot completely rule out any effect of potential cortisol in fetal bovine serum used in this study, the effect from 1% fetal serum is likely to be minimal, given that fetal bovine plasma cortisol levels ranged from 3 to 8 ng/ml (23, 39) , which would result in maximal cortisol levels of 0.03-0.08 ng/ml in the medium. Regardless of the source of cortisol, the finding that carbenoxolone selectively potentiated NE-induced contractions in the pregnant uterine artery is intriguing and suggests an increase in type 2 11-␤HSD activity in the uterine artery in pregnancy. The effect of glucocorticoids on vascular reactivity is regulated by 11-␤HSD (41). The two 11-␤HSD isozymes catalyze the interconversion of cortisol and cortisone. Type 1 11-␤HSD has bidirectional activity, whereas type 2 mainly converts cortisol into cortisone, the biologically inactive form. Both type 1 and 2 11-␤HSD have been found in vascular endothelial (7) and smooth muscle cells (6, 42) . Numerous studies have demonstrated that inhibition of 11-␤HSD with an enzyme inhibitor such as carbenoxolone increases cortisol-mediated potentiation of vascular response to NE (5, 22, 41, 42) . Although under normal conditions the type 1 isoform dominates, functioning in the oxo-reductase mode, which converts cortisone to cortisol in both endothelial and smooth muscle cells, the two major isoforms are compartmentalized discretely and regulated differentially by steroids such as estrogen and progesterone (38) . In human pregnancy, placental type 2 11-␤HSD activity increases markedly in the third trimester of pregnancy, at a time when maternal circulating levels of glucocorticoid are rising, which serves as a protective mechanism for the fetus (36) . The present study suggests an increase in type 2 11-␤HSD activity in the uterine artery, which is likely to play an important role in the local regulation of cortisol concentration by limiting the effect of cortisol on the uterine artery and protecting it from elevated cortisol levels during pregnancy.
The present study demonstrated that cortisol significantly decreased NO release in the uterine artery. In addition, removal of the endothelium diminished cortisol-mediated potentiation of NE-induced contractions. These studies suggest that the effect of cortisol on NO production plays an important role in cortisolmediated potentiation of uterine artery contractility. Previous reports concerning the effects of cortisol on NO synthesis/release are controversial. It has been suggested that stress-induced increase in plasma NO production is cortisol independent in the rat (24) . Studies (14, 21) in humans showed that mental stress induced transient endothelial dysfunction and cortisol treatment significantly reduced plasma nitrate/nitrite concentrations and increased blood pressure. In addition, studies in adrenalectomized sheep have demonstrated that withdrawal of glucocorticoid replacement resulted in reduced blood pressure and pressor responsiveness, which could be restored by the NO synthase inhibitor N G -nitro-L-arginine methyl ester (34) . In the present study, the effect of cortisol on NO production in the uterine artery was examined by directly measuring NO release. The finding of increased NO release in pregnant versus nonpregnant uterine arteries is in agreement with our previous studies (46, 47) . Cortisol significantly decreased NO release in the uterine artery, which was associated with a reduction in eNOS protein levels in uterine artery endothelial scrapings. A recent study (43) in cultured human umbilical vein endothelial cells demonstrated that glucocorticoids decreased eNOS promoter activity and mRNA stability. We and others have demonstrated that both eNOS protein and mRNA levels are significantly increased in pregnant uterine artery endothelial cells (4, 26, 27, 31, 46, 47) . The present finding that the degree of cortisolmediated inhibition of eNOS protein expression was decreased in the pregnant uterine artery may be due in part to the increased eNOS in pregnant uterine artery. Carbenoxolone decreased eNOS protein levels in both nonpregnant and pregnant uterine arteries but significantly decreased NO release only in pregnant uterine arteries. This discrepancy between eNOS protein levels and NO release is not entirely clear at present but may involve the regulation of eNOS activity. The finding that carbenoxolone had no effect on NO release in nonpregnant uterine arteries but significantly decreased NO release in pregnant uterine arteries is consistent with the contraction studies in which carbenoxolone increased NE-induced contraction only in pregnant uterine arteries, suggesting that endothelial effect may play an important role in carbenoxolonemediated potentiation of NE-induced contraction. This also suggests an increase in type 2 11-␤HSD activity in pregnant uterine artery endothelial cells.
In summary, the results indicate that cortisol plays an important role in the regulation of uterine artery contractility, and its effect is endothelium dependent. Downregulation of eNOS protein expression and NO synthesis/release is likely to contribute to the cortisolmediated potentiation of uterine artery contraction. More importantly, pregnancy selectively attenuates uterine artery sensitivity to cortisol. Although this decreased sensitivity may not be mediated by a decrease in GR density, the effect of pregnancy on the availability and binding affinity of GRs in the uterine artery remains to be determined. In addition, pregnancy may increase type 2 11-␤HSD activity in uterine artery endothelial and smooth muscle cells, which is likely to provide a local protection for the uterine artery to the increased cortisol levels in pregnancy.
